FM
AMRI

Forward Management’s Albany Molecular Research Inc AMRI Stock Holding History

Forward Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-112,715
Closed -$1.65M – 392
2015
Q1 		$1.65M Sell
112,715
-16,685
-13% -$284K 0.1% 121
2014
Q4 		$1.92M Buy
+129,400
New +$2.37M 0.11% 113
2014
Q2 		– Sell
-48,560
Closed -$717K – 393
2014
Q1 		$717K Buy
+48,560
New +$669K 0.04% 183

Other funds holding AMRI

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Forward Management's AMRI Position: Q2 2015 in Review

Forward Management sold out of Albany Molecular Research Inc (AMRI) in Q2 2015, closing a stake of 112,715 shares — an estimated $1.65M sold.

Forward Management first reported a position in AMRI in Q1 2014 and held it in 3 quarters. The position peaked at $1.92M in Q4 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q2 2015.

  • Forward Management reported no remaining Albany Molecular Research Inc position as of Q2 2015 after selling out during the quarter.
  • Forward Management sold 112,715 Albany Molecular Research Inc shares in Q2 2015, an estimated $1.65M.
  • Forward Management first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 3 quarters.
  • Forward Management's Albany Molecular Research Inc position peaked at $1.92M in Q4 2014.
  • 131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2015.

Based on Forward Management's 13F filing for Q2 2015, filed 11 Aug 2015.